BRCA2 and pancreatic neoplasm: The observed dichotomy in precursor lesions between the Brca1-deficient and Brca2-deficient tumors and the mixture of both in Palb2 deficient tumors might provide insights into mechanisms underlying the higher pancreatic cancer incidence and aggressiveness in BRCA2 vs BRCA1 mutation carriers.